Our findings suggest that identifying potential pathways and molecular targets affected by NOS1AP isoforms, as we have done in this study, may prove important for understanding the cognitive deficits observed in schizophrenia and can guide future therapeutic studies. The gene discussed is NOS1AP; the disease is schizophrenia.